我如何做到:维护avelumab对于晚期泌尿腺癌的治疗
1Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada.
The Canadian journal of urology
|August 26, 2023
概括
使用PD-L1抑制剂阿维卢马布的维护疗法显著改善了在基化疗后晚期泌尿腺癌患者的整体存活率. 这种免疫疗法现在是第一线治疗的关键组成部分,提高了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 尿癌研究 尿癌研究
背景情况:
- 40多年来,以白金为基础的化疗一直是晚期泌尿腺癌 (aUC) 的标准.
- 癌症生物学和瘤微环境理解的近期进展导致了新的治疗策略.
- 针对PD-1/PD-L1的免疫检查点抑制剂 (ICI) 现在是aUC管理的组成部分.
研究的目的:
- 讨论阿维卢马布维持治疗在晚期泌尿腺癌中的作用.
- 为了确定患者群体谁可以从阿维卢马布治疗中受益.
- 审查阿维卢马布治疗的方法,益处和副作用管理.
主要方法:
- 对JAVELIN Bladder 100试验数据的分析.
- 对接受阿维卢马布维护治疗的患者的整体存活 (OS) 的评估与最佳支持性护理.
- 临床指导方针的审查和FDA对aUC的avelumab的批准.
主要成果:
- 在第一线化疗后,维护avelumab在患有稳定疾病或更好的患者中与最佳支持性护理相比,大约7个月显著改善了OS.
- 艾维卢马布在aUC患者的生存率和生活质量有所提高.
- 2020年6月,FDA批准了阿维卢马布作为维持疗法.
结论:
- 维护阿维卢马布应纳入先进泌尿腺癌患者的标准一线治疗方案.
- 阿维卢马布代表了aUC治疗的重大进步,提供了更好的生存结果.
- 了解avelumab的利用,患者选择和管理对于最佳的患者护理至关重要.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Urinary Bladder
907
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
907
